These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3761137)

  • 21. Effect of dimethadione derived from repeated oral administration of trimethadione on pancreatic secretion in dogs.
    Noda A; Okumura I; Ibuki E; Hotta S; Nomoto K; Miyamoto E; Takeuchi K; Watanabe T
    Gastroenterol Jpn; 1990 Oct; 25(5):613-8. PubMed ID: 2227252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trimethadione as a model drug for the evaluation of hepatic drug-metabolizing capacity in normal and alpha-naphthylisothiocyanate-intoxicated rats.
    Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
    Pharmacology; 1982; 25(4):202-9. PubMed ID: 7146085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of short-term water deprivation on kinetics of trimethadione and its metabolite in rats.
    Tanaka E; Kurata N; Kuroiwa Y; Misawa S
    Jpn J Pharmacol; 1986 Oct; 42(2):269-74. PubMed ID: 3795625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-related changes in trimethadione oxidizing capacity.
    Tanaka E; Ishikawa A; Ono A; Okamura T; Misawa S
    Br J Clin Pharmacol; 1987 Mar; 23(3):355-7. PubMed ID: 3567052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trimethadione metabolism, a useful indicator for assessing hepatic drug-oxidizing capacity.
    Nakamura M; Tanaka E; Misawa S; Shimada T; Imaoka S; Funae Y
    Biochem Pharmacol; 1994 Jan; 47(2):247-51. PubMed ID: 8304968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trimethadione tolerance tests for the assessment of feasible size of hepatic resection in patients with hepatocellular carcinoma.
    Ishikawa A; Fukao K; Tsuji K; Osada A; Yamamoto Y; Ohtsuka M; Tanaka E
    J Gastroenterol Hepatol; 1993; 8(5):426-32. PubMed ID: 8218989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic studies of trimethadione and its metabolite in rats with chemical-induced liver injury.
    Tanaka E; Kinoshita H; Yamamoto T; Kuroiwa Y; Takabatake E
    J Pharmacobiodyn; 1981 Aug; 4(8):576-83. PubMed ID: 7299621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trimethadione as a model drug for the evaluation of hepatic drug-metabolizing capacity in normal and D-galactosamine intoxicated rats.
    Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
    Jpn J Pharmacol; 1982 Dec; 32(6):1182-5. PubMed ID: 7161969
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of organic solvents on trimethadione n-demethylation in rats.
    Nishimura Y; Kurata N; Iwase M; Li H; Yasuhara H
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):229-39. PubMed ID: 10634315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of plasma trimethadione and its metabolite carbon tetrachloride-intoxicated rat liver: a useful tool for estimation of hepatic drug metabolizing capacity.
    Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
    J Pharmacobiodyn; 1981 Dec; 4(12):961-7. PubMed ID: 7341752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of the trimethadione tolerance test in chronic hepatitis: a useful indicator of hepatic drug metabolizing capacity.
    Abei M; Tanaka E; Tanaka N; Matsuzaki Y; Ikegami T; Ishikawa A; Osuga T
    J Gastroenterol; 1995 Aug; 30(4):478-84. PubMed ID: 7550858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-independent pharmacokinetics of trimethadione and its metabolite in rats.
    Tanaka E; Yoshida T; Kuroiwa Y
    J Pharm Sci; 1985 Mar; 74(3):340-1. PubMed ID: 4009447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: trimethadione and antipyrine metabolism as an indicator.
    Tanaka E; Kobayashi S; Aramphongphan A; Kurata N; Oguchi K; Kuroiwa Y; Yasuhara H
    J Pharmacobiodyn; 1985 Sep; 8(9):773-9. PubMed ID: 4087137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metabolism and excretion of trimethadione in patients with percutaneous transhepatic biliary drainage and renal dysfunction.
    Tanaka E; Ishikawa A; Yamamoto Y; Fukao K; Iwasaki Y; Misawa S
    J Pharmacobiodyn; 1989 Mar; 12(3):145-8. PubMed ID: 2760794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of inhibitors and substrates of different types of cytochrome P450 isozymes on serum dimethadione/trimethadione ratio in rats in vivo.
    Nishimura Y; Kurata N; Kobayashi S; Uchida E; Yasuhara H
    Res Commun Mol Pathol Pharmacol; 1995 Feb; 87(2):145-54. PubMed ID: 7749652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trimethadione metabolism as an index of hepatic drug-oxidizing capacity in dogs with liver ischemia.
    Tanaka E; Otsuka M; Yuzawa K; Isikawa A; Fukao K; Iwasaki Y
    Drug Metab Dispos; 1992; 20(5):773-4. PubMed ID: 1358585
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of the effects of trimethadione and its primary metabolite dimethadione on neuromuscular function and the effects of altered pH on the actions of dimethadione.
    Alderdice MT; McMillan JE
    J Pharmacol Exp Ther; 1982 Jun; 221(3):547-51. PubMed ID: 6283057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simplified approach for evaluation of hepatic drug-oxidizing activity with a simultaneous determination of caffeine and trimethadione and their demethylated metabolites in rats with a selective cytochrome P-450 inducer.
    Tanaka E; Ishikawa A; Yamamoto Y; Uchida E; Kobayashi S; Yasuhara H; Misawa S
    Biopharm Drug Dispos; 1992 May; 13(4):263-72. PubMed ID: 1600112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trimethadione tolerance test for the quantitative assessment of liver function in rats.
    Ishikawa A; Fukao K; Tanaka E; Tsuji K; Osada A; Yamamoto Y; Kiyosawa T; Iwasaki Y
    J Gastroenterol Hepatol; 1991; 6(4):363-7. PubMed ID: 1912445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trimethadione N-demethylation by rat liver CYP2E1 in vitro.
    Nishimura Y; Kurata N; Watanabe M; Uchida E; Yasuhara H
    Res Commun Mol Pathol Pharmacol; 1996 Jul; 93(1):43-56. PubMed ID: 8865369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.